Congressional Committee Leader Targets Centers for Medicare & Medicaid For Slow Changes of Antipsychotic Drug Use in Nursing Homes
Rep. Richard Neal (D-MA) is the author of a January 22, 2019 letter sent to the Centers for Medicare & Medicaid (CMS) administrator, Seema Verma. In the letter, the congressional committee leader overseeing Medicare says he wants to see a closer look at how nursing homes are really using antipsychotics and is also asking for greater detail on how skilled nursing facilities (SNFs) and Medicare plans alike are actively changing the way the drugs are being used. Although antipsychotic drug overuse, theft, and abuse in nursing homes have been long-time issues in the U.S., CMS’s 2019 trend update on the problem shows nursing homes are making progress in decreasing antipsychotic prescribing.
“CMS is tracking the progress of the National Partnership to Improve Dementia Care in Nursing Homes by reviewing publicly reported measures. The official measure of the Partnership is the percentage of long-stay nursing home residents who receive antipsychotic medication, excluding residents diagnosed with schizophrenia, Huntington’s disease, or Tourette’s syndrome. In the fourth quarter of 2011, 23.9 percent of residents received an antipsychotic medication; since then there has been a decrease of 38.9 percent to a national prevalence of 14.6 percent in the second quarter of 2018. Success varies by state and CMS region; some states and regions have a reduction greater than 40 percent.”